Insider · CIK 0001797388

Schick Kelly

Reports to the SEC for 2 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001797388

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-14	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief People Officer	MExercise/Conversion	+21K sh	—	—	307,150
2026-02-14	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−7,269 sh	$1.89	−$13.7K	299,881
2026-02-13	CCCCC4 Therapeutics, Inc.A Award	Chief People Officer	AAward	+200K sh	—	—	308,885
2026-02-13	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief People Officer	MExercise/Conversion	+5,000 sh	—	—	308,885
2026-02-13	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−1,735 sh	$1.89	−$3,279.15	307,150
2025-02-14	CCCCC4 Therapeutics, Inc.A Award	Chief People Officer	AAward	+56.5K sh	—	—	111,253
2025-02-14	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−2,368 sh	$3.18	−$7,530.24	108,885
2025-02-14	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief People Officer	AAward	+84.7K sh	—	—	84,700
2025-02-13	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−1,735 sh	$3.20	−$5,552	54,753
2024-11-07	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief People Officer	MExercise/Conversion	+3,750 sh	—	—	57,590
2024-11-07	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−1,102 sh	$6.04	−$6,656.08	56,488
2024-11-07	CCCCC4 Therapeutics, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	Chief People Officer	MExercise/Conversion	−3,750 sh	—	—	10,500
2024-09-16	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief People Officer	MExercise/Conversion	+2,250 sh	—	—	54,501
2024-09-16	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−661 sh	$6.36	−$4,203.96	53,840
2024-09-16	CCCCC4 Therapeutics, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	Chief People Officer	MExercise/Conversion	−2,250 sh	—	—	14,250
2024-03-07	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief People Officer	DDisposition to Issuer	−92K sh	—	—	0
2024-03-07	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief People Officer	AAward	+92K sh	—	—	92,000
2024-03-07	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief People Officer	DDisposition to Issuer	−78.5K sh	—	—	0
2024-03-07	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief People Officer	AAward	+78.5K sh	—	—	78,500
2024-02-14	CCCCC4 Therapeutics, Inc.A Award	Chief People Officer	AAward	+27.3K sh	—	—	52,251
2024-02-14	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief People Officer	AAward	+123K sh	—	—	122,800
2024-02-13	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−1,735 sh	$6.53	−$11.3K	24,951
2023-09-18	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief People Officer	AAward	+120K sh	—	—	120,000
2023-08-30	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief People Officer	MExercise/Conversion	+2,250 sh	—	—	27,347
2023-08-30	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−661 sh	$2.93	−$1,936.73	26,686
2023-08-30	CCCCC4 Therapeutics, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	Chief People Officer	MExercise/Conversion	−2,250 sh	—	—	16,500
2023-02-13	CCCCC4 Therapeutics, Inc.A Award	Chief People Officer	AAward	+20K sh	—	—	25,097
2023-02-13	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief People Officer	AAward	+90K sh	—	—	90,000
2023-01-30	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief People Officer	MExercise/Conversion	+3,750 sh	—	—	6,398
2023-01-30	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−1,301 sh	$7.78	−$10.1K	5,097
2023-01-30	CCCCC4 Therapeutics, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	Chief People Officer	MExercise/Conversion	−3,750 sh	—	—	18,750
2022-05-26	CCCCC4 Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−1,102 sh	$7.01	−$7,725.02	2,648
2022-05-25	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief People Officer	MExercise/Conversion	+3,750 sh	—	—	3,750
2022-05-25	CCCCC4 Therapeutics, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	Chief People Officer	MExercise/Conversion	−3,750 sh	—	—	22,500
2020-11-16	AMAG PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Human Resources Officer	DDisposition to Issuer	−28.2K sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Human Resources Officer	DDisposition to Issuer	−7,000 sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Human Resources Officer	DDisposition to Issuer	−6,900 sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Human Resources Officer	DDisposition to Issuer	−17K sh	—	—	0
2020-04-02	AMAG PHARMACEUTICALS, INC.F Tax Payment	Chief Human Resources Officer	FTax Payment	−79 sh	$6.18	−$488.22	28,155
2020-03-10	AMAG PHARMACEUTICALS, INC.A Award	Chief Human Resources Officer	AAward	+13K sh	—	—	28,234
2020-03-10	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Chief Human Resources Officer	AAward	+17K sh	—	—	17,000
2020-03-02	AMAG PHARMACEUTICALS, INC.F Tax Payment	Chief Human Resources Officer	FTax Payment	−358 sh	$7.75	−$2,774.5	15,234
2020-02-25	AMAG PHARMACEUTICALS, INC.F Tax Payment	Chief Human Resources Officer	FTax Payment	−1,095 sh	$8.84	−$9,679.8	15,592
2020-02-23	AMAG PHARMACEUTICALS, INC.F Tax Payment	Chief Human Resources Officer	FTax Payment	−463 sh	$9.50	−$4,398.5	16,687

Recent filings

Accepted (ET)
Feb 184
Schick Kelly0001470831-26-000178
SEC(opens sec.gov)
Feb 184
Schick Kelly0001662579-25-000017
SEC(opens sec.gov)
Nov 124
Schick Kelly0001662579-24-000102
SEC(opens sec.gov)
Sep 174
Schick Kelly0001662579-24-000080
SEC(opens sec.gov)
Mar 84
Schick Kelly0001662579-24-000028
SEC(opens sec.gov)
Feb 154
Schick Kelly0001662579-24-000017
SEC(opens sec.gov)

Companies

Address

C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY #120

WATERTOWN, MA, 02472